@article{e6d8ca27c1da4e419ca48539c09a21eb,
title = "Letter to the Editor: Not the Last Word: Prizes for Cures",
author = "O'Keefe, {Regis J.}",
note = "Funding Information: When investigators make a major breakthrough, it is not an accident. Such innovations occur after years of scientific study and development, requiring advanced skills and imagination, a rigorous scientific approach, and the ability to remain resilient in the face of failure. The discovery may cure a disease, as is the case with the recent development of chimeric antigen receptor T-cell therapy from refractory large B-cell lymphoma [5]. Under our intellectual property system, successful and highly innovative scientists can reap financial rewards of a far greater magnitude than could be provided by a Prizes for Cures program. Each year, tens of thousands of patents are awarded by the US Patent Office. Essentially all major academic medical centers in the United States have Technology Transfer Offices that fund and facilitate the development of patents related to academic research. Moreover, most major medical centers have incubator programs to support companies during the early phase of development. Finally, the NIH has a granting program, the Small Business Innovation Research/Small Business Technology Transfer grant mechanism, that supports startup companies utilizing intellectual property in developing products to treat human diseases.",
year = "2019",
month = dec,
day = "1",
doi = "10.1097/CORR.0000000000001027",
language = "English",
volume = "477",
pages = "2804--2805",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
number = "12",
}